ストックスクリーナーアプリを入手
1.29
10.42%
-0.15
Pepgen Inc (PEPG) 最新ニュース
FY2029 Earnings Estimate for PepGen Issued By HC Wainwright - Defense World
H.C. Wainwright cuts PepGen stock target to $16, maintains Buy rating - Investing.com India
JPMorgan Chase & Co. Increases Holdings in PepGen Inc. (NASDAQ:PEPG) - Defense World
HC Wainwright Lowers PepGen (NASDAQ:PEPG) Price Target to $16.00 - Defense World
PepGen (NASDAQ:PEPG) Price Target Lowered to $16.00 at HC Wainwright - MarketBeat
PepGen price target lowered to $16 from $26 at H.C. Wainwright - Yahoo Finance
PepGen stock plunges to 52-week low of $1.76 amid market challenges - Investing.com
PepGen continues trials for DMD treatment, addresses safety concerns By Investing.com - Investing.com South Africa
PepGen continues trials for DMD treatment, addresses safety concerns - Investing.com India
PepGen's Duchenne Treatment Hits Roadblock: Key Safety Concerns Emerge - StockTitan
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - PR Newswire
PepGen stock hits 52-week low at $2.21 amid market challenges - MSN
Barclays PLC Has $189,000 Stake in PepGen Inc. (NASDAQ:PEPG) - Defense World
PepGen stock hits 52-week low at $2.21 amid market challenges By Investing.com - Investing.com South Africa
PepGen Inc. (NASDAQ:PEPG) Short Interest Down 14.1% in December - MarketBeat
PepGen stock hits 52-week low at $2.88 amid market challenges - Investing.com Australia
PepGen stock hits 52-week low at $2.88 amid market challenges By Investing.com - Investing.com South Africa
Jane Street Group LLC Purchases 6,254 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World
All You Need to Know About PepGen (PEPG) Rating Upgrade to Buy - Yahoo Finance
Barclays PLC Has $189,000 Stock Position in PepGen Inc. (NASDAQ:PEPG) - Defense World
Geode Capital Management LLC Has $3.21 Million Stock Holdings in PepGen Inc. (NASDAQ:PEPG) - Defense World
Wedbush Comments on PepGen’s FY2028 Earnings (NASDAQ:PEPG) - Defense World
Fmr LLC Sells 327,160 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World
Wedbush Has Bullish Forecast for PepGen FY2028 Earnings - MarketBeat
FDA Pauses PepGen’s DMD Drug Trial in the US - AJMC.com Managed Markets Network
PepGen stock craters 35% on FDA clinical hold - MSN
PepGen (NASDAQ:PEPG) Downgraded by Bank of America to Underperform - Defense World
FDA halts PepGen's DMD trial; ongoing study continues By Investing.com - Investing.com Australia
PepGen stock touches 52-week low at $2.9 amid market challenges - Investing.com
FDA halts PepGen's DMD trial; ongoing study continues - Investing.com India
PepGen shares downgraded to Underperform by BofA amid uncertainty over clinical hold - Investing.com
PepGen stock down 22% on FDA clinical hold (update) (PEPG:NASDAQ) - Seeking Alpha
Novo builds up manufacturing; Pepgen Duchenne trial put on hold - BioPharma Dive
PepGen stock touches 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa
Déjà Vu for PepGen as FDA Places Hold on DMD Drug - BioSpace
PepGen Shares Tumble Premarket as FDA Puts Study on Clinical Hold - MarketWatch
FDA Places Clinical Hold on PepGen's Phase 2 DMD Trial, Canadian Study Advances - StockTitan
When (PEPG) Moves Investors should Listen - Stock Traders Daily
Frazier Life Sciences Management L.P. Sells 800,094 Shares of PepGen Inc. (NASDAQ:PEPG) - MarketBeat
3.95%
2.39%
大文字化:
|
ボリューム (24 時間):